α-Bromo-2-iodotoluene
Names
[ CAS No. ]:
40400-13-3
[ Name ]:
α-Bromo-2-iodotoluene
[Synonym ]:
o-Iodobenzyl bromide
α-Bromo-2-iodotoluene
2-Iodobenzyl bromide
1-(Bromomethyl)-2-iodobenzene
IR B1E
MFCD00236046
1-(Bromomethyl)iodobenzene
Benzene, 1-(bromomethyl)-2-iodo-
2-Iodo benzylbromide
Chemical & Physical Properties
[ Density]:
2.1±0.1 g/cm3
[ Boiling Point ]:
278.8±15.0 °C at 760 mmHg
[ Melting Point ]:
54-60 °C(lit.)
[ Molecular Formula ]:
C7H6BrI
[ Molecular Weight ]:
296.931
[ Flash Point ]:
122.4±20.4 °C
[ Exact Mass ]:
295.869751
[ LogP ]:
3.95
[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C
[ Index of Refraction ]:
1.656
[ Storage condition ]:
Refrigerator
MSDS
Safety Information
[ Symbol ]:
GHS05, GHS07, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H302-H314-H334
[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338-P310
[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
[ Hazard Codes ]:
C:Corrosive;N:Dangerousfortheenvironment;
[ Risk Phrases ]:
R22;R34;R43;R51/53
[ Safety Phrases ]:
S26-S36/37/39-S61-S45
[ RIDADR ]:
UN 3261 8/PG 2
[ WGK Germany ]:
2
[ Hazard Class ]:
8.0
[ HS Code ]:
2903999090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2903999090
[ Summary ]:
2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%
Articles
J. Comb. Chem. 11(1) , 34-43, (2009)
For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib...
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.J. Comb. Chem. 11 , 14-33, (2009)
Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa...